These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21856394)

  • 21. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
    Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
    J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
    Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
    J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
    Zintchenko A; Philipp A; Dehshahri A; Wagner E
    Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular delivery of nanoparticles with CPPs.
    Sawant R; Torchilin V
    Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Charge Type, Charge Spacing, and Hydrophobicity of Arginine-Rich Cell-Penetrating Peptides Dictate Gene Transfection.
    Alhakamy NA; Dhar P; Berkland CJ
    Mol Pharm; 2016 Mar; 13(3):1047-57. PubMed ID: 26878305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
    Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
    J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
    Fang B; Jiang L; Zhang M; Ren FZ
    Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
    Kapoor M; Burgess DJ; Patil SD
    Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.
    Lin D; Huang Y; Jiang Q; Zhang W; Yue X; Guo S; Xiao P; Du Q; Xing J; Deng L; Liang Z; Dong A
    Biomaterials; 2011 Nov; 32(33):8730-42. PubMed ID: 21885115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy.
    Buyens K; Meyer M; Wagner E; Demeester J; De Smedt SC; Sanders NN
    J Control Release; 2010 Jan; 141(1):38-41. PubMed ID: 19737587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
    Gary DJ; Puri N; Won YY
    J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
    Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
    Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.